Literature DB >> 19515838

emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development.

Andrew C Steer1, Graham Magor, Adam W J Jenney, Joseph Kado, Michael F Good, David McMillan, Michael Batzloff, Jonathan R Carapetis.   

Abstract

We designed a study to investigate the molecular epidemiology of group A streptococcal (GAS) and group C and G streptococcal (GCS and GGS) disease in Fiji, a country which is known to have a high burden of streptococcal disease. Molecular typing of the N-terminal portion (emm typing) of the M protein was performed with 817 isolates (535 GAS and 282 GCS/GGS). We also performed genotyping of the C-repeat region in 769 of these isolates to identify J14 sequence types. The profile of emm types for Fiji was very different from that found for the United States and Europe. There were no dominant emm types and a large number of overlapping types among clinical disease states. Commonly found GAS emm types in industrialized countries, including emm1, emm12, and emm28, were not found among GAS isolates from Fiji. Over 93% of GAS isolates and over 99% of GCS/GGS isolates that underwent J14 sequence typing contained either J14.0 or J14.1. Our data have implications for GAS vaccine development in developing countries and suggest that a vaccine based upon the conserved region of the M protein may be a feasible option for Fiji and potentially for other tropical developing countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515838      PMCID: PMC2725645          DOI: 10.1128/JCM.00312-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms.

Authors:  H Grundmann; S Hori; G Tanner
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.

Authors:  Stanford T Shulman; Robert R Tanz; William Kabat; Kathleen Kabat; Emily Cederlund; Devendra Patel; Zhongya Li; Varja Sakota; James B Dale; Bernard Beall
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

3.  Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries.

Authors:  Varja Sakota; Alicia M Fry; Thomas M Lietman; Richard R Facklam; Zhongya Li; Bernard Beall
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci.

Authors:  W J Simpson; J M Musser; P P Cleary
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Group C streptococci: "Streptococcus equisimilis" or Streptococcus anginosus?

Authors:  D W Vance
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

Review 6.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

7.  Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis.

Authors:  A L Bisno; I A Pearce; H P Wall; M D Moody; G H Stollerman
Journal:  N Engl J Med       Date:  1970-09-10       Impact factor: 91.245

8.  The presence of type 12 M-protein antigen in group G streptococci.

Authors:  W R Maxted; E V Potter
Journal:  J Gen Microbiol       Date:  1967-10

9.  M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.

Authors:  Wezenet Tewodros; Göran Kronvall
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

10.  Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever.

Authors:  D Bessen; K F Jones; V A Fischetti
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  25 in total

1.  Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates.

Authors:  F Koutouzi; A Tsakris; P Chatzichristou; E Koutouzis; G L Daikos; E Kirikou; N Petropoulou; V Syriopoulou; A Michos
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 2.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

Review 3.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

Review 4.  Molecular epidemiology and genomics of group A Streptococcus.

Authors:  Debra E Bessen; W Michael McShan; Scott V Nguyen; Amol Shetty; Sonia Agrawal; Hervé Tettelin
Journal:  Infect Genet Evol       Date:  2014-10-30       Impact factor: 3.342

5.  M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).

Authors:  Jamie-Lee S Mills; Cesar M Jayashi Flores; Manisha Pandey; Michael F Good; Simone Reynolds; Christine Wun; Ainslie Calcutt; S Ben Baker; Senthil Murugappan; Alexandra C I Depelsenaire; Jessica Dooley; Paul V Fahey; Angus H Forster
Journal:  NPJ Vaccines       Date:  2020-08-07       Impact factor: 7.344

6.  In vivo efficacy of a chimeric peptide derived from the conserved region of the M protein against group C and G streptococci.

Authors:  Therese Nordström; Jessica Malcolm; Graham Magor; Michael F Good; Michael R Batzloff
Journal:  Clin Vaccine Immunol       Date:  2012-10-17

7.  Whole-genome association study on tissue tropism phenotypes in group A Streptococcus.

Authors:  Debra E Bessen; Nikhil Kumar; Gerod S Hall; David R Riley; Feng Luo; Sergio Lizano; Candace N Ford; W Michael McShan; Scott V Nguyen; Julie C Dunning Hotopp; Hervé Tettelin
Journal:  J Bacteriol       Date:  2011-09-23       Impact factor: 3.490

8.  Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes.

Authors:  E Burlet; H HogenEsch; A Dunham; G Morefield
Journal:  AAPS J       Date:  2017-03-10       Impact factor: 4.009

9.  Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.

Authors:  Thomas A Penfound; Edna Y Chiang; Elwaleed A Ahmed; James B Dale
Journal:  Vaccine       Date:  2010-05-21       Impact factor: 3.641

10.  Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Authors:  Davina Gorton; Suchandan Sikder; Natasha L Williams; Lisa Chilton; Catherine M Rush; Brenda L Govan; Madeleine W Cunningham; Natkunam Ketheesan
Journal:  Autoimmunity       Date:  2016-08-25       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.